The article presents the results of a randomized, open, comparative study of the effect of carbocisteine lysine salt in patients with chronic obstructive pulmonary disease with frequent exacerbations. The results demonstrate that carbocisteine lysine salt facilitates sputum properties (decreased purulence and improved expectoration), reduces the need for bronchodilators, increases exercise tolerance, and reduces frequency, severity and duration of exacerbations
Background: To date there are no head-to-head studies comparing different mucolytic/antioxidant agen...
Abstract: The use of bacterial lysates to reduce acute exacerbations of COPD (AECOPDs) is an intrigu...
Yoshinosuke Fukuchi,1 Koichiro Tatsumi,2 Hiromasa Inoue,3 Yukinori Sakata,4 Kai Shibata,4 Hideaki Mi...
OBJECTIVE: COPD is one of the major causes of morbidity and mortality worldwide and represents one o...
Background Chronic obstructive pulmonary disease (COPD) is characterised by airflow limitation, and ...
Chronic Obstructive Pulmonary Disease (COPD) is a chronic and progressive lung disease characterized...
The paper gives information on current mucoactive therapy with carbocysteine for acute and chronic b...
BACKGROUND: Reactive oxygen radicals are involved in many respiratory diseases, including chronic ob...
Chronic obstructive pulmonary disease (COPD) is characterized by an airways inflammation and by an e...
Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease with a versatile and complic...
Abstract: Background: Carbocysteine is a muco-active drug with free radical scavenging and anti-infl...
Exacerbations of chronic obstructive pulmonary disease (COPD) are periods in the chronic course of t...
OBJECTIVE: Standard treatment for chronic obstructive pulmonary disease (COPD) includes inhalation t...
The effects of adding L-carnitine to a whole-body and respiratory training program were determined i...
A single-blind study is reported of S-carboxymethylcysteine, administered as a 5% w/v syrup at a dos...
Background: To date there are no head-to-head studies comparing different mucolytic/antioxidant agen...
Abstract: The use of bacterial lysates to reduce acute exacerbations of COPD (AECOPDs) is an intrigu...
Yoshinosuke Fukuchi,1 Koichiro Tatsumi,2 Hiromasa Inoue,3 Yukinori Sakata,4 Kai Shibata,4 Hideaki Mi...
OBJECTIVE: COPD is one of the major causes of morbidity and mortality worldwide and represents one o...
Background Chronic obstructive pulmonary disease (COPD) is characterised by airflow limitation, and ...
Chronic Obstructive Pulmonary Disease (COPD) is a chronic and progressive lung disease characterized...
The paper gives information on current mucoactive therapy with carbocysteine for acute and chronic b...
BACKGROUND: Reactive oxygen radicals are involved in many respiratory diseases, including chronic ob...
Chronic obstructive pulmonary disease (COPD) is characterized by an airways inflammation and by an e...
Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease with a versatile and complic...
Abstract: Background: Carbocysteine is a muco-active drug with free radical scavenging and anti-infl...
Exacerbations of chronic obstructive pulmonary disease (COPD) are periods in the chronic course of t...
OBJECTIVE: Standard treatment for chronic obstructive pulmonary disease (COPD) includes inhalation t...
The effects of adding L-carnitine to a whole-body and respiratory training program were determined i...
A single-blind study is reported of S-carboxymethylcysteine, administered as a 5% w/v syrup at a dos...
Background: To date there are no head-to-head studies comparing different mucolytic/antioxidant agen...
Abstract: The use of bacterial lysates to reduce acute exacerbations of COPD (AECOPDs) is an intrigu...
Yoshinosuke Fukuchi,1 Koichiro Tatsumi,2 Hiromasa Inoue,3 Yukinori Sakata,4 Kai Shibata,4 Hideaki Mi...